A total of 12,811 (69.2%) patients received chemotherapy in our cohort and this proportion had increased very slightly over the study period showing a borderline significant trend (test for trends 0.055).
← all excerpts
Small-cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit.
1
—
—